+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Digital Therapeutics Market by Product Type, Therapy Area, Platform, Channel Type, End User, Deployment Mode - Global Forecast 2026-2032- Product Image
Digital Therapeutics Market by Product Type, Therapy Area, Platform, Channel Type, End User, Deployment Mode - Global Forecast 2026-2032- Product Image
Sale

Digital Therapeutics Market by Product Type, Therapy Area, Platform, Channel Type, End User, Deployment Mode - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5336451
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Digital Therapeutics Market is projected to reach USD 7.37 Billion in 2026. It is expected to continue growing at a CAGR of 15.92%, reaching USD 18.05 Billion by 2032.

Digital therapeutics (DTx) are evidence-based software interventions designed to prevent, manage, or treat disease, often used independently or alongside medication, devices, and clinician-led care. The category is moving from wellness-adjacent apps toward regulated medical software supported by randomized clinical trials, real-world evidence, cybersecurity controls, interoperability standards, and reimbursement pathways.

Demand is being reinforced by durable health system pressures: chronic disease prevalence, behavioral health shortages, aging populations, and the need to extend care beyond hospitals and clinics. Verified policy signals, including FDA oversight of software as a medical device, Germany’s DiGA pathway, the U.K.’s DTAC framework, France’s PECAN early access pathway for digital medical devices, and U.S. remote therapeutic monitoring codes, show that digital therapeutics are becoming a formal part of connected care infrastructure.

Transformative Shifts in the Digital Therapeutics Landscape

The digital therapeutics landscape is shifting from direct-to-consumer experimentation to enterprise adoption by providers, payers, employers, pharmaceutical stakeholders, and public health systems. Buyers increasingly require clinical validation, health economic evidence, workflow integration, usability testing, data security, and measurable outcomes before scaling solutions across populations.

A second shift is the convergence of DTx with telehealth, remote patient monitoring, electronic health records, pharmacy services, and value-based care contracts. This integration is changing the competitive benchmark: successful platforms must not only engage patients, but also deliver longitudinal data, clinician decision support, adherence insights, and compliance with privacy, accessibility, and medical device regulations.

Cumulative Impact of Artificial Intelligence on Digital Therapeutics

Artificial intelligence is amplifying the value of digital therapeutics by enabling adaptive interventions, personalized coaching, risk stratification, natural-language engagement, and automated escalation to care teams. AI can help match intervention intensity to patient behavior, comorbidities, social risk factors, and response patterns, improving the relevance of therapy between clinical visits.

The cumulative impact is also increasing regulatory and governance expectations. Industry leaders must validate AI models across diverse populations, monitor algorithm drift, document clinical safety, protect health data, and maintain explainability where outputs affect treatment. Responsible AI is becoming a competitive differentiator as payers, providers, and regulators demand evidence that digital therapeutics are safe, equitable, clinically meaningful, and auditable over time.

Key Regional Insights for Digital Therapeutics Adoption

North America remains a leading region for digital therapeutics commercialization due to advanced digital health infrastructure, payer experimentation, FDA precedent for prescription digital therapeutics, and employer demand for scalable chronic and behavioral health solutions. The United States is the primary commercialization engine, supported by remote therapeutic monitoring reimbursement codes and value-based care adoption, while Canada benefits from strong public health digitization, provincial virtual care initiatives, and growing attention to chronic disease management.

Europe is shaped by structured assessment and reimbursement models, particularly Germany’s DiGA program, France’s digital medical device reimbursement initiatives, the U.K.’s DTAC assessment framework, and broader EU emphasis on GDPR, medical device regulation, interoperability, and evidence-based software. Asia-Pacific is expanding as China, Japan, India, South Korea, and Australia invest in telehealth, mobile-first care, digital hospitals, and aging-population management. Latin America shows rising demand in diabetes, cardiovascular risk, mental health, and access-to-care use cases, with Brazil and Mexico acting as important adoption centers. The Middle East is accelerating through national digital health strategies in Gulf markets, where prevention, chronic care, and smart hospital programs are policy priorities. Africa remains earlier-stage but strategically important, with mobile health adoption, primary care access gaps, expanding broadband initiatives, and donor-supported digital health infrastructure creating long-term DTx opportunities.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are attractive for mobile-first digital therapeutics because smartphone penetration, urban healthcare demand, and public-private digital health initiatives are increasing across Singapore, Indonesia, Malaysia, Thailand, Vietnam, and the Philippines. Adoption is strongest where solutions support diabetes, cardiometabolic disease, mental health, respiratory care, and medication adherence while fitting local reimbursement, language, clinical workflow, and data residency requirements.

The European Union is advancing a rules-based DTx environment through GDPR, medical device regulation, health data space initiatives, cross-border interoperability priorities, and national reimbursement experiments. GCC countries are investing in digital health as part of economic diversification, preventive care strategies, and health system modernization, creating favorable conditions for digitally enabled chronic disease and behavioral health programs. BRICS markets represent scale, chronic disease burden, and cost-sensitive innovation potential, although regulatory heterogeneity, reimbursement fragmentation, and access disparities remain significant. G7 markets provide the deepest evidence, reimbursement, procurement, and clinical integration opportunities, while NATO countries overlap substantially with high-income digital health systems prioritizing cybersecurity, resilience, continuity of care, and trusted health data exchange.

Key Country Insights for Digital Therapeutics Growth

The United States leads in DTx commercialization, supported by FDA-recognized pathways for software-based medical interventions, CPT codes for remote therapeutic monitoring, established digital health procurement channels, and employer and payer interest in outcomes-based care. Canada is advancing virtual care and chronic disease management through provincial systems and national digital health collaboration, while Mexico and Brazil offer large populations, rising chronic disease needs, and growing private-sector demand for scalable digital health access.

In Europe, the United Kingdom’s NHS assessment frameworks, Germany’s DiGA reimbursement pathway, and France’s digital medical device reimbursement initiatives make these markets influential for evidence standards and procurement expectations. Italy and Spain are strengthening telehealth, electronic health records, and chronic care modernization, while Russia remains complex due to geopolitical, reimbursement, and procurement constraints. In Asia-Pacific, China offers scale and policy-driven digital health expansion, India provides mobile-first demand and substantial chronic disease needs, Japan prioritizes aging-related care, regulated quality, and clinical safety, Australia supports remote care across dispersed populations, and South Korea combines strong connectivity with advanced digital hospital ecosystems and government interest in smart healthcare.

Actionable Recommendations for Digital Therapeutics Leaders

Industry leaders should prioritize clinically validated use cases where digital therapeutics can demonstrate measurable outcomes, such as diabetes, hypertension, insomnia, substance use disorder, musculoskeletal care, respiratory disease, obesity, cardiovascular risk management, and behavioral health. Evidence strategies should combine randomized trials, real-world evidence, patient-reported outcomes, health economics, adherence metrics, safety monitoring, and subgroup analyses to support reimbursement and procurement.

Companies should also design for integration from the start. Interoperability with EHRs, remote monitoring devices, pharmacy systems, care management platforms, and clinician workflows improves adoption and reduces abandonment. Leaders should invest in privacy-by-design, cybersecurity, health equity testing, AI governance, accessibility, localization, and payer-aligned value propositions that translate engagement into reduced utilization, improved adherence, better quality measures, and sustained patient outcomes.

Research Methodology for Digital Therapeutics Analysis

A robust digital therapeutics research methodology should triangulate regulatory documents, peer-reviewed clinical evidence, payer policies, reimbursement codes, clinical practice guidelines, public health datasets, procurement activity, patent filings, product registries, and expert interviews. Market assessment should distinguish wellness apps from clinically validated DTx, software as a medical device, remote monitoring, connected disease management, and digital care navigation platforms to avoid category inflation.

The methodology should evaluate adoption by indication, care setting, business model, regulatory classification, evidence maturity, prescribing pathway, reimbursement readiness, and integration depth. Regional analysis should incorporate healthcare financing, data protection laws, physician adoption, smartphone access, digital literacy, language localization, procurement models, and health system priorities. AI-related analysis should review validation protocols, bias mitigation, post-market surveillance, model governance, explainability, algorithm change control, and clinical safety documentation.

Conclusion: Digital Therapeutics as a Core Healthcare Growth Market

Digital therapeutics are becoming a strategic layer of modern healthcare, connecting patients, clinicians, payers, and life sciences stakeholders through clinically guided software interventions. The market’s next phase will be defined less by app downloads and more by evidence, reimbursement, integration, cybersecurity, regulatory alignment, and sustained health outcomes.

Organizations that combine medical rigor with user-centered design, responsible AI, secure data practices, interoperability, and scalable partnerships will be best positioned to lead. As healthcare systems seek accessible, cost-effective, and personalized care models, digital therapeutics are set to play an expanding role in chronic disease management, behavioral health, preventive care, and digitally enabled population health.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Digital Therapeutics Market, by Product Type
7.1. Non-Prescription / Over-the-Counter (OTC) Digital Therapeutics
7.2. Prescription Digital Therapeutics (PDTx)
8. Digital Therapeutics Market, by Therapy Area
8.1. Diabetes Management
8.2. Neurological Disorders
8.2.1. Depression
8.2.2. Anxiety Disorders
8.2.3. Schizophrenia
8.2.4. Epilepsy
8.2.5. Multiple Sclerosis
8.3. Obesity & Weight Management
8.4. Chronic Respiratory Diseases
8.5. Cardiovascular Diseases
8.6. Mental & Behavioral Health
8.7. Musculoskeletal Disorders / Pain Management
8.8. Oncology Support Care
8.9. Gastrointestinal Disorders
8.10. Smoking Cessation
8.11. Women’s Health
8.12. Rehabilitation & Physical Therapy
8.13. Substance Use Disorders
8.14. Sleep Disorders
9. Digital Therapeutics Market, by Platform
9.1. Smartphone-Based Applications
9.2. Wearable Device-Integrated DTx
9.3. AI/ML-Based Digital Therapies
9.4. Virtual Reality (VR)-Based DTx
9.5. Digital Monitoring + Feedback Systems
9.6. Web-Based / Cross-Platform Therapeutics
10. Digital Therapeutics Market, by Channel Type
10.1. Patients / Direct-to-Consumer (D2C)
10.2. Healthcare Providers (Hospitals & Clinics)
10.3. Employers / Corporate Wellness Programs
10.4. Pharmaceutical Partnerships
10.5. Government & Public Health Systems
11. Digital Therapeutics Market, by End User
11.1. Patients
11.2. Healthcare Providers
11.3. Employers & Corporate Wellness
11.4. Caregivers & Rehabilitation Centers
12. Digital Therapeutics Market, by Deployment Mode
12.1. Cloud-Based
12.2. On-Premise
12.3. Hybrid Deployment
13. Europe Digital Therapeutics Market
14. Asia-Pacific Digital Therapeutics Market
15. North America Digital Therapeutics Market
16. Latin America Digital Therapeutics Market
17. Africa Digital Therapeutics Market
18. Middle East Digital Therapeutics Market
19. NATO Digital Therapeutics Market
20. G7 Digital Therapeutics Market
21. BRICS Digital Therapeutics Market
22. European Union Digital Therapeutics Market
23. ASEAN Digital Therapeutics Market
24. GCC Digital Therapeutics Market
25. United States Digital Therapeutics Market
26. China Digital Therapeutics Market
27. Germany Digital Therapeutics Market
28. Japan Digital Therapeutics Market
29. Canada Digital Therapeutics Market
30. United Kingdom Digital Therapeutics Market
31. India Digital Therapeutics Market
32. Brazil Digital Therapeutics Market
33. France Digital Therapeutics Market
34. Mexico Digital Therapeutics Market
35. South Korea Digital Therapeutics Market
36. Russia Digital Therapeutics Market
37. Australia Digital Therapeutics Market
38. Italy Digital Therapeutics Market
39. Spain Digital Therapeutics Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. 2morrow Inc.
41.2. Abbott Laboratories
41.3. AptarGroup, Inc.
41.4. Big Health, Inc.
41.5. Biofourmis Inc.
41.6. Canary Health Technologies Inc.
41.7. Click Therapeutics, Inc.
41.8. CogniFit Inc.
41.9. Cognoa, Inc.
41.10. CureApp, Inc.
41.11. DarioHealth Corp.
41.12. F. Hoffmann-La Roche Ltd
41.13. Fitterfly Healthtech Private Limited by PB Healthcare Services Pvt. Ltd.
41.14. GAIA AG
41.15. Glooko, Inc.
41.16. Grünenthal GmbH
41.17. H2O Therapeutics Co.
41.18. Headspace Inc.
41.19. Hinge Health, Inc.
41.20. Hyfe, Inc.
41.21. Kaia Health Software Inc.
41.22. Lark Technologies, Inc.
41.23. LifeScan, Inc.
41.24. Lumanity Inc.
41.25. Lumos Labs
41.26. MedRhythms
41.27. Noom, Inc.
41.28. Novartis AG
41.29. Novo Nordisk A/S
41.30. Omada Health, Inc.
41.31. Otsuka Holdings Co., Ltd.
41.32. ResMed, Inc.
41.33. SilverCloud by American Well Corporation
41.34. Teladoc Health, Inc.
41.35. Teva Pharmaceutical Industries Ltd.
41.36. Vida Health, Inc.
41.37. Virtual Therapeutics Corp.
41.38. Welldoc, Inc.
List of Figures
FIGURE 1. GLOBAL DIGITAL THERAPEUTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DIGITAL THERAPEUTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DIGITAL THERAPEUTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2025 VS 2032 (%)
FIGURE 21. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
FIGURE 25. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. CHINA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. CANADA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. INDIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. ITALY DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DIGITAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NON-PRESCRIPTION / OVER-THE-COUNTER (OTC) DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NON-PRESCRIPTION / OVER-THE-COUNTER (OTC) DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NON-PRESCRIPTION / OVER-THE-COUNTER (OTC) DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DEPRESSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DEPRESSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DEPRESSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ANXIETY DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ANXIETY DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ANXIETY DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SCHIZOPHRENIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SCHIZOPHRENIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SCHIZOPHRENIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL OBESITY & WEIGHT MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL OBESITY & WEIGHT MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL OBESITY & WEIGHT MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CHRONIC RESPIRATORY DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CHRONIC RESPIRATORY DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CHRONIC RESPIRATORY DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MENTAL & BEHAVIORAL HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MENTAL & BEHAVIORAL HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MENTAL & BEHAVIORAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MUSCULOSKELETAL DISORDERS / PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MUSCULOSKELETAL DISORDERS / PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MUSCULOSKELETAL DISORDERS / PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ONCOLOGY SUPPORT CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ONCOLOGY SUPPORT CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ONCOLOGY SUPPORT CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL SMOKING CESSATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL SMOKING CESSATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL SMOKING CESSATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL WOMEN’S HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL WOMEN’S HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL WOMEN’S HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL REHABILITATION & PHYSICAL THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL REHABILITATION & PHYSICAL THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL REHABILITATION & PHYSICAL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL SUBSTANCE USE DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL SUBSTANCE USE DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL SUBSTANCE USE DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL SLEEP DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL SLEEP DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL SLEEP DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL SMARTPHONE-BASED APPLICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL SMARTPHONE-BASED APPLICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL SMARTPHONE-BASED APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL WEARABLE DEVICE-INTEGRATED DTX MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL WEARABLE DEVICE-INTEGRATED DTX MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL WEARABLE DEVICE-INTEGRATED DTX MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL AI/ML-BASED DIGITAL THERAPIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL AI/ML-BASED DIGITAL THERAPIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL AI/ML-BASED DIGITAL THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL VIRTUAL REALITY (VR)-BASED DTX MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL VIRTUAL REALITY (VR)-BASED DTX MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL VIRTUAL REALITY (VR)-BASED DTX MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DIGITAL MONITORING + FEEDBACK SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DIGITAL MONITORING + FEEDBACK SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DIGITAL MONITORING + FEEDBACK SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL WEB-BASED / CROSS-PLATFORM THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL WEB-BASED / CROSS-PLATFORM THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL WEB-BASED / CROSS-PLATFORM THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PATIENTS / DIRECT-TO-CONSUMER (D2C) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PATIENTS / DIRECT-TO-CONSUMER (D2C) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PATIENTS / DIRECT-TO-CONSUMER (D2C) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL HEALTHCARE PROVIDERS (HOSPITALS & CLINICS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL HEALTHCARE PROVIDERS (HOSPITALS & CLINICS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL HEALTHCARE PROVIDERS (HOSPITALS & CLINICS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL EMPLOYERS / CORPORATE WELLNESS PROGRAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL EMPLOYERS / CORPORATE WELLNESS PROGRAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL EMPLOYERS / CORPORATE WELLNESS PROGRAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PHARMACEUTICAL PARTNERSHIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PHARMACEUTICAL PARTNERSHIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PHARMACEUTICAL PARTNERSHIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL GOVERNMENT & PUBLIC HEALTH SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL GOVERNMENT & PUBLIC HEALTH SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL GOVERNMENT & PUBLIC HEALTH SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL PATIENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL PATIENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL PATIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL EMPLOYERS & CORPORATE WELLNESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL EMPLOYERS & CORPORATE WELLNESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL EMPLOYERS & CORPORATE WELLNESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL CAREGIVERS & REHABILITATION CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL CAREGIVERS & REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL CAREGIVERS & REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL CLOUD-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL CLOUD-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL CLOUD-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ON-PREMISE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ON-PREMISE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ON-PREMISE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL HYBRID DEPLOYMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL HYBRID DEPLOYMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL HYBRID DEPLOYMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 133. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 134. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 135. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 136. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 137. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. EUROPE DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 163. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 166. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 167. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 168. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 169. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 179. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 181. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 182. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 183. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 184. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 185. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. NATO DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 187. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 188. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 189. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 190. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 191. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 192. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 193. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. G7 DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 195. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 196. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 197. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 198. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 199. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 200. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 201. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. BRICS DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 211. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 212. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 214. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 215. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 216. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 217. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. ASEAN DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 219. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 220. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 221. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 222. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 223. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 224. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 225. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. GCC DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 235. CHINA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 237. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 238. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 239. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 240. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 241. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 243. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 244. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 245. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 246. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 247. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 248. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 249. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 250. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 251. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 252. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 253. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 254. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 255. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 256. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 257. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 259. CANADA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 260. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 261. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 262. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 263. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 264. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 265. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 267. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 268. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 269. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 270. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 271. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 272. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 273. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 274. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 275. INDIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 276. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 277. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 278. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 279. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 280. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 281. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 282. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 283. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 285. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 286. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 287. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 288. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 289. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 290. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 291. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 292. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 293. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 294. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 295. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 296. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 297. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 298. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 299. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 300. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 301. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 302. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 303. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 304. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 305. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 306. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 307. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 308. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 309. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 310. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 311. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 312. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 313. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 314. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 315. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 316. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 317. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 318. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 319. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 320. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 321. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 322. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 323. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 324. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 325. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 326. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 327. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 328. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 329. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 330. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 331. ITALY DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 332. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 333. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 334. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 335. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 336. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 337. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 338. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 339. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 340. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 341. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY THERAPY AREA, 2018-2032 (USD MILLION)
TABLE 342. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 343. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY PLATFORM, 2018-2032 (USD MILLION)
TABLE 344. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY CHANNEL TYPE, 2018-2032 (USD MILLION)
TABLE 345. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 346. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Digital Therapeutics market report include:
  • 2morrow Inc.
  • Abbott Laboratories
  • AptarGroup, Inc.
  • Big Health, Inc.
  • Biofourmis Inc.
  • Canary Health Technologies Inc.
  • Click Therapeutics, Inc.
  • CogniFit Inc.
  • Cognoa, Inc.
  • CureApp, Inc.
  • DarioHealth Corp.
  • F. Hoffmann-La Roche Ltd
  • Fitterfly Healthtech Private Limited by PB Healthcare Services Pvt. Ltd.
  • GAIA AG
  • Glooko, Inc.
  • Grünenthal GmbH
  • H2O Therapeutics Co.
  • Headspace Inc.
  • Hinge Health, Inc.
  • Hyfe, Inc.
  • Kaia Health Software Inc.
  • Lark Technologies, Inc.
  • LifeScan, Inc.
  • Lumanity Inc.
  • Lumos Labs
  • MedRhythms
  • Noom, Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Omada Health, Inc.
  • Otsuka Holdings Co., Ltd.
  • ResMed, Inc.
  • SilverCloud by American Well Corporation
  • Teladoc Health, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Vida Health, Inc.
  • Virtual Therapeutics Corp.
  • Welldoc, Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.37 Billion
Forecasted Market Value ( USD ) by 2032 $ 18.05 Billion
Compound Annual Growth Rate15.9%
Regions CoveredGlobal
No. of Companies Mentioned39

Related Topics

Related Reports

Digital Therapeutic Devices Market by Therapeutic Area, Delivery Mode, Distribution Channel, End User - Global Forecast 2026-2032 - Product Image

Digital Therapeutic Devices Market by Therapeutic Area, Delivery Mode, Distribution Channel, End User - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Digital Therapeutics Market (By Component, Application, End User, Region), Company Profiles, Recent Developments, Market Dynamics - Growth Trends and Forecast (2025-2032) - Product Image

Digital Therapeutics Market (By Component, Application, End User, Region), Company Profiles, Recent Developments, Market Dynamics - Growth Trends and Forecast (2025-2032)

  • Report
  • 105 Pages
  • Global
From
Digital Therapeutics Market Report and Forecast 2025-2034 - Product Image

Digital Therapeutics Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Digital Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024-2032 - Product Image

Digital Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024-2032

  • Report
  • 150 Pages
  • Global
From
Digital Therapeutics Market Report by Application, End Use, and Region 2026-2034 - Product Image

Digital Therapeutics Market Report by Application, End Use, and Region 2026-2034

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.